[111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: Receptor bindingin vitro andin vivo-Reference-Cited by-同舟云学术

[111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: Receptor bindingin vitro andin vivo

Published:1994-09-01 Issue:5 Volume:58 Page:749-755
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bagutti Claudia,Stolz Barbara,Albert Rainer,Bruns Christian,Pless Janos,Eberle Alex N.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

2. A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma

3. Targeting of a chelating derivative of a short-chain analogue of α-melanocyte stimulating hormone to Cloudman S91 melanomas

4. , , and , In: and (eds.) The use of derivatives of α-MSH for targeting to melanomas in vivo. Toweling of drugs 3: The challenge of peptides and proteins, Plenum Press, New York, (1992).

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 靶向MC1R的NIR-II聚集诱导发射纳米颗粒用于黑色素瘤成像;Science China Materials;2023-09-21

2. MC1R and melanin-based molecular probes for theranostic of melanoma and beyond;Acta Pharmacologica Sinica;2022-08-25

3. Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2017-10

4. Synthetic Peptide Drugs for Targeting Skin Cancer: Malignant Melanoma and Melanotic Lesions;Current Medicinal Chemistry;2017-07-04

5. Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand;Frontiers in Endocrinology;2017-04-26